Feed Preview

CREs: Gene & Cell Therapy

CREs: Gene & Cell Therapy diagram by Sripa et al, Wikimedia
Sripa et al, Wikimedia

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Top 20 most recent papers
Nature Reviews. Cancer

Tumour heterogeneity and the evolutionary trade-offs of cancer

Nature Reviews. CancerFebruary 26, 2020
Jean Hausser, Uri Alon
31
Nature Genetics

Systematic identification of silencers in human cells

Nature GeneticsFebruary 26, 2020
Baoxu Pang, Michael P Snyder
158
Antiviral Research

Influenza virus NS1- C/EBPβ gene regulatory complex inhibits RIG-I transcription

Antiviral ResearchFebruary 25, 2020
Rashmi KumariSunil K Lal
2
Cell Chemical Biology

MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome

Cell Chemical BiologyFebruary 27, 2020
ZhiJun QiuRicardo C T Aguiar
Bulletin du cancer

Current advances in immunotherapy in ovarian cancer

Bulletin du cancerFebruary 25, 2020
Olivia Le SauxIsabelle Ray-Coquard
3
American Journal of Respiratory Cell and Molecular Biology

Serine Protease Imbalance in the Small Airways and Development of Centrilobular Emphysema in COPD

American Journal of Respiratory Cell and Molecular BiologyFebruary 27, 2020
Kiyoshi UemasuAtsuyasu Sato
Scientific Reports

Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis

Scientific ReportsFebruary 27, 2020
Minoru FujimotoTetsuji Naka
Journal for Immunotherapy of Cancer

CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency

Journal for Immunotherapy of CancerFebruary 27, 2020
Feng LiYi Zhang
Nanoscale

Functional nanoarrays for investigating stem cell fate and function

NanoscaleFebruary 25, 2020
Jin-Ho LeeJeong-Woo Choi
bioRxiv

Regulated control of gene therapies with a drug induced switch

bioRxivFebruary 24, 2020
Alex Mas MonteysBeverly L Davidson
2

See more papers from this feed

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

© 2020 Meta ULC. All rights reserved
/feed-previews/cres-gene-cell-therapy/11f7e9dd-4d93-4a75-8b49-575856953088